Alexis Peyroles
Vorstandsvorsitzender bei Ose Immunotherapeutics, Inc.
Vermögen: 6 Mio $ am 30.04.2024
Aktive Positionen von Alexis Peyroles
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Aperana Consulting SAS | Vorsitzender | - | - |
| Ose Immunotherapeutics, Inc. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Alexis Peyroles
Ehemalige bekannte Positionen von Alexis Peyroles
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Direktor/Vorstandsmitglied | 01.05.2016 | 16.01.2022 |
| Vorstandsvorsitzender | 12.04.2018 | 16.01.2022 | |
| Geschäftsführer | 01.05.2016 | 12.04.2018 | |
| Guerbet Imagem do Brasil Ltda. | Vorstandsvorsitzender | 01.01.2009 | - |
| Sanofi-Aventis Japan | Comptroller/Controller/Auditor | 01.01.1996 | - |
| GUERBET | Comptroller/Controller/Auditor | 01.01.2005 | - |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | 01.01.1996 | - |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Finanzdirektor/CFO | 01.09.2013 | - |
Ausbildung von Alexis Peyroles
| École des Hautes Études Commerciales du Nord | Undergraduate Degree |
| Imperial College Business School | Masters Business Admin |
Statistik
International
| Frankreich | 7 |
| Vereinigte Staaten | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Executive Officer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GUERBET | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
| Aperana Consulting SAS | |
| Ose Immunotherapeutics, Inc. | |
| Sanofi-Aventis Japan | |
| Guerbet Imagem do Brasil Ltda. |
- Börse
- Insiders
- Alexis Peyroles
- Erfahrung
